Syngene International, contract research arm of biotechnology major Biocon is planning to set up a new manufacturing plant in Mangalore SEZ with an investment of about USD 100 million. The company is in the process of acquiring 40 acres of land and obtaining necessary approvals. Currently, the company offers discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition.
Company Profile : Syngene
Leave a Reply